Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform
September 10, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors
September 05, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
August 26, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Aviv Clinics Congratulates Peter Paltchik on Winning Bronze at the 2024 Paris Olympics
August 22, 2024 09:00 ET
|
Aviv Clinics
ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain and performance clinics in the world, congratulates Peter Paltchik on his bronze medal win in the Men’s...
Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
August 22, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative...
Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders
August 21, 2024 09:00 ET
|
Firefly Neuroscience, Inc.
TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative...
DiagnaMed Expands with Drug and Clinical Research AI Platform
August 21, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development and discovering potential novel treatments for...
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
August 15, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
August 13, 2024 16:06 ET
|
Firefly Neuroscience, Inc.
Firefly Neuroscience CEO Issues Letter to Stockholders
Following Closing of Merger and Listing on Nasdaq
AFS Introduces MycoThrive™ Lion's Mane: A Clinically Studied Ingredient for Cognitive Performance
July 13, 2024 12:55 ET
|
Applied Food Sciences, Inc.
Kerrville, Texas, July 13, 2024 (GLOBE NEWSWIRE) -- Applied Food Sciences (AFS) is proud to announce the launch of MycoThrive™ Lion's Mane, a groundbreaking functional ingredient recently clinically...